ArticleFrontiers in medicine2021
Evaluation of the Good Review Practices of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Transitioning regulatory authorities in South Africa: a comparative review of the organisational structure and management practices.Journal of pharmaceutical policy and practice · 2026Review
- Assessing the Malaysian Regulatory Process for Medicinal Product Approval: An OpERA Methodology and Standardized Reporting Approach.Therapeutic innovation & regulatory science · 2025Article
- The Economic Impact of Reliance on an African Medicines Regulatory Authority.Pharmaceutical medicine · 2025Article
- Lessons from Ethiopian pharmaceutical regulation: a risk-based approach to overcome challenges and unlock opportunities.Frontiers in medicine · 2025Article
- Comparison of the review models and regulatory timelines of seven countries participating in the ECOWAS-MRH initiative: identifying opportunities for improvement.Frontiers in medicine · 2025Article
- Good manufacturing practice inspections conducted by Tanzania medicines and medical devices authority: a comparative study of two fiscal years from 2018 to 2020.Journal of pharmaceutical policy and practice · 2024Article
- Identifying and costing common gaps in Central and West Africa pharmaceutical regulation.Frontiers in medicine · 2024Article
- Evaluation of good review practices in member authorities of the East African Medicines Regulatory Harmonisation initiative: strategies for alignment with African medicines agency.Frontiers in medicine · 2024Article
- Comparison of good review practices of seven countries participating in the ECOWAS medicines regulatory harmonisation initiative: identifying opportunities for improvement.Frontiers in medicine · 2024Article
- The domestication of the African Union model law on medical products regulation: Perceived benefits, enabling factors, and challenges.Frontiers in medicine · 2023Article
- What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements.Frontiers in medicine · 2023Review
- Situation analysis on the regulation of nanomedicines in Southern Africa.Frontiers in medicine · 2023Article
- Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency.Pharmaceutical medicine · 2022Article
- Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward.Frontiers in medicine · 2022Article
- Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward.Frontiers in medicine · 2022Article
- Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.Frontiers in medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.